Cognition Therapeutics, Inc. (CGTX) Free cash flow 2021–2025
Cognition Therapeutics, Inc. (CGTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$24.6MFY2025 · since FY2021: -$3.6M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +14.1% |
| FY2024 | -$28.6M | -76.8% |
| FY2023 | -$16.2M | +12.8% |
| FY2022 | -$18.6M | -409.8% |
| FY2021 | -$3.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CGTX financial trends
CGTX RevenueCGTX Net incomeCGTX Net marginCGTX Gross profitCGTX Gross marginCGTX Operating incomeCGTX Operating marginCGTX Operating cash flowCGTX Capital expendituresCGTX Return on equityCGTX Stock buybacksCGTX Dividends paidCGTX Total assetsCGTX Total liabilitiesCGTX Shareholders’ equityCGTX overview →